S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get 12 Months of Stock Picks for $9.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get 12 Months of Stock Picks for $9.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get 12 Months of Stock Picks for $9.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get 12 Months of Stock Picks for $9.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
NASDAQ:TCBP

TC Biopharm (TCBP) Stock Price, News & Analysis

$3.17
+0.27 (+9.31%)
(As of 12/29/2023 ET)
Today's Range
$2.81
$4.15
50-Day Range
$2.07
$100.00
52-Week Range
$2.03
$192.20
Volume
766,154 shs
Average Volume
137,453 shs
Market Capitalization
$2.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1,400.00

TC Biopharm MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
44,064.0% Upside
$1,400.00 Price Target
Short Interest
Healthy
5.72% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.44mentions of TC Biopharm in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars


TCBP stock logo

About TC Biopharm Stock (NASDAQ:TCBP)

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

TCBP Stock Price History

TCBP Stock News Headlines

TC BioPharm Prices Offering Of 1.75 Mln American Depositary Shares
New Year's Sale: Get MarketBeat All Access Free For 30 Days
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscription
New Year's Sale: Get MarketBeat All Access Free For 30 Days
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscription
TC Biopharm (Holdings) Plc (TCBP)
TCBP TC Biopharm (Holdings) Plc
What's Going On With TC BioPharm Stock?
TC BioPharm Announces $7.35 Million Private Placement
See More Headlines
Receive TCBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/31/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TCBP
Fax
N/A
Employees
60
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1,400.00
High Stock Price Target
$1,400.00
Low Stock Price Target
$1,400.00
Potential Upside/Downside
+44,064.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.76 million
Book Value
($0.67) per share

Miscellaneous

Free Float
633,000
Market Cap
$2.38 million
Optionable
Not Optionable
Beta
0.32
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Bryan L. Kobel (Age 42)
    CEO & Director
  • Mr. Martin E. Thorp (Age 71)
    CFO & Director
  • Mr. Christopher Camarra
    Executive Vice President of Communications














TCBP Stock Analysis - Frequently Asked Questions

Should I buy or sell TC Biopharm stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TC Biopharm in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TCBP shares.
View TCBP analyst ratings
or view top-rated stocks.

What is TC Biopharm's stock price target for 2024?

1 brokers have issued 1-year price objectives for TC Biopharm's stock. Their TCBP share price targets range from $1,400.00 to $1,400.00. On average, they predict the company's share price to reach $1,400.00 in the next twelve months. This suggests a possible upside of 44,064.0% from the stock's current price.
View analysts price targets for TCBP
or view top-rated stocks among Wall Street analysts.

How have TCBP shares performed in 2023?

TC Biopharm's stock was trading at $770.00 on January 1st, 2023. Since then, TCBP stock has decreased by 99.6% and is now trading at $3.17.
View the best growth stocks for 2023 here
.

When did TC Biopharm's stock split?

TC Biopharm's stock reverse split on Friday, December 15th 2023. The 1-20 reverse split was announced on Friday, December 15th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did TC Biopharm IPO?

(TCBP) raised $17 million in an initial public offering on Friday, February 11th 2022. The company issued 4,100,000 shares at a price of $4.25 per share. EF Hutton served as the underwriter for the IPO.

How do I buy shares of TC Biopharm?

Shares of TCBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TCBP) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -